English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Pathological mechanisms and therapeutic strategies for Alzheimer's disease Review article
2022
Authors:  Ju, Yaojun;  Tam, Kin
Favorite | TC[WOS]:202 TC[Scopus]:222  IF:5.9/5.2 | Submit date：2022/03/28
Alzheimer's Disease  Drug Development  Multiple Pathologies  Pathological Pathways  
Pathological mechanisms and therapeutic strategies for Alzheimer's disease Journal article
Ju Yaojun, TAM KIN YIP. Pathological mechanisms and therapeutic strategies for Alzheimer's disease[J]. Neural Regeneration Research, 2022, 17(3), 543-549.
Authors:  Ju Yaojun;  TAM KIN YIP
Adobe PDF | Favorite | TC[WOS]:202 TC[Scopus]:222  IF:5.9/5.2 | Submit date：2024/08/29
Alzheimer’s Disease  Pathological Pathways  Drug Development  Multiple Pathologies  
Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation Journal article
Zhang,Qingyu, Zhou,Wei, Yu,Shan, Ju,Yaojun, To,Sally Kit Yan, Wong,Alice Sze Tsai, Jiao,Yufei, Poon,Terence Chuen Wai, Tam,Kin Yip, Lee,Leo Tsz On. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation[J]. Oncogene, 2021, 40(1), 97-111.
Authors:  Zhang,Qingyu;  Zhou,Wei;  Yu,Shan;  Ju,Yaojun;  To,Sally Kit Yan; et al.
Favorite | TC[WOS]:38 TC[Scopus]:41  IF:6.9/7.5 | Submit date：2021/03/04
An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease Journal article
Ju,Yaojun, Chakravarty,Harapriya, Tam,Kin Yip. An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease[J]. ACS Chemical Neuroscience, 2020, 11(20), 3346-3357.
Authors:  Ju,Yaojun;  Chakravarty,Harapriya;  Tam,Kin Yip
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.1/4.3 | Submit date：2021/03/04
Alzheimer's Disease  Amyloid Beta  Cholinesterase  Dual Inhibition  
9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model Journal article
Ju,Yaojun, Tam,Kin Yip. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model[J]. Neuropharmacology, 2020, 181, 108354.
Authors:  Ju,Yaojun;  Tam,Kin Yip
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:4.6/4.5 | Submit date：2021/03/04
Cholinesterase  Amyloid Beta  Dual Inhibition  Multifunction  Alzheimer's Disease  
Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives Journal article
Chakravarty,Harapriya, Ju,Yaojun, Chen,Wen Hua, Tam,Kin Y.. Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives[J]. DRUG DEVELOPMENT RESEARCH, 2020, 81(2), 242-255.
Authors:  Chakravarty,Harapriya;  Ju,Yaojun;  Chen,Wen Hua;  Tam,Kin Y.
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:3.5/4.0 | Submit date：2021/03/04
Acetylcholinesterase  Alzheimer's Disease  Amyloid Beta  Butyrylcholinesterase  Dual Target Inhibitor  Isoquinolinium  Pyridinium